Maria L Thompson, Brian Schryver & Rolf O Ehrhardt
The cell therapy industry continues to gain momentum as an increasing number of treatments move forward from clinical trials to commercialization. Recent changes in regulatory language and procedures specifically recognize the potential of cell-based therapeutics. The expected and observed boost in manufacturing of cellular therapies must be accompanied by innovations in the post-production processing of these products to accommodate the higher production volume and increased variety of cellular therapies. Novel post-production technologies facilitate and accelerate product delivery, allowing manufactured live cell therapies to reach patients more reliably and efficiently. This article reviews a select number of the latest innovations projected to drive successful commercialization of cell therapy products.
Submitted for review: Apr 26 2017 Published: July 19 2017
Citation: Cell Gene Therapy Insights 2017; 433-441.